<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-84839</identifier>
<setSpec>0210-5705</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">How long should combined the rapy with biological and immunomodulatory agents be maintained in inflammatory bowel disease?</dc:title>
<dc:creator>López San Román, Antonio</dc:creator>
<dc:creator>Domènech,  Eugeni</dc:creator>
<dc:creator>Garcia-Planella,  Esther</dc:creator>
<dc:language>es</dc:language>
<dc:source>Gastroenterol Hepatol;33(6): 471-472, Jun. -Jul. 2010.</dc:source>
<dc:identifier>ibc-84839</dc:identifier>
<dc:title xml:lang="es">¿Hasta cuándo mantener el tratamiento combinado de biológicos e inmunomoduladores en la enfermedad inflamatoria intestinal?</dc:title>
<dc:subject>^d28622</dc:subject>
<dc:subject>^d29625</dc:subject>
<dc:subject>^d23973^s22057</dc:subject>
<dc:subject>^d30602</dc:subject>
<dc:subject>^d29638</dc:subject>
<dc:subject>^d23973^s22067</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d23695^s22067</dc:subject>
<dc:subject>^d22431</dc:subject>
<dc:subject>^d23695^s22057</dc:subject>
<dc:subject>^d1713^s22073</dc:subject>
<dc:subject>^d1713^s22000</dc:subject>
<dc:subject>^d7336^s22000</dc:subject>
<dc:subject>^d1394^s22073</dc:subject>
<dc:subject>^d7336^s22073</dc:subject>
<dc:subject>^d920^s22073</dc:subject>
<dc:type>article</dc:type>
<dc:date>201007</dc:date>
</metadata>
</record>
</ibecs-document>
